What is liquid biopsy and how is it used for Melanoma

Liquid Biopsy and Melanoma: What You Should Know

What Is a Liquid Biopsy?

A liquid biopsy is a blood test that looks for cancer cells or cancer-related material circulating in your bloodstream. Instead of removing tissue from your skin (like a traditional skin biopsy), doctors draw blood and analyze it for signs of cancer. This is why it's called "liquid" — they're sampling your blood rather than solid tissue.

How Liquid Biopsy Works

In a liquid biopsy, doctors look for several things in your blood:

• Circulating tumor DNA (ctDNA) — pieces of DNA shed by cancer cells into the bloodstream
• Circulating tumor cells (CTCs) — actual cancer cells floating in your blood
• Exosomes — tiny packages released by cancer cells that contain genetic material
• Biomarkers — specific proteins or genetic changes associated with melanoma

Current Use in Melanoma Care

Based on the NCCN Guidelines for Patients: Melanoma (2025), the guidelines emphasize traditional testing methods like skin biopsy and BRAF mutation testing for diagnosing and staging melanoma. However, liquid biopsy is an emerging tool being studied in clinical trials for melanoma patients.

Where Liquid Biopsy Shows Promise:

Monitoring for recurrence — After treatment, liquid biopsy may help detect if melanoma is returning before it shows up on imaging or physical exams

Detecting circulating tumor DNA — This can indicate whether cancer cells are present in your bloodstream, which may suggest higher risk of spread

Tracking treatment response — Changes in the amount of cancer DNA in your blood may show whether your current treatment is working

Important Limitations

According to current NCCN Guidelines, liquid biopsy is not yet standard for routine melanoma diagnosis or staging. Here's why:

• It's still being studied in clinical trials
• It's not yet FDA-approved as a standalone diagnostic test for melanoma
• Traditional skin biopsy remains the gold standard for diagnosis
• Results need to be interpreted carefully by your oncology team

Questions to Ask Your Care Team

If you're interested in liquid biopsy testing:

1. "Is liquid biopsy appropriate for my stage of melanoma?"
2. "Are there clinical trials available that include liquid biopsy testing?"
3. "How would liquid biopsy results change my treatment plan?"
4. "What are the limitations of liquid biopsy for my specific situation?"
5. "Would liquid biopsy help monitor me during follow-up care?"

The Bottom Line

Liquid biopsy is a promising technology for melanoma care, but it's still primarily a research tool. The NCCN Guidelines continue to recommend traditional testing methods (skin biopsy, imaging, and BRAF testing) as the standard approach. However, as research advances, liquid biopsy may play an increasingly important role in detecting recurrence and monitoring treatment response.

Your oncology team can discuss whether participating in a clinical trial involving liquid biopsy might be appropriate for your individual situation.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.